Gritstone Oncology is a cancer immunotherapy company developing next-generation personalized cancer therapeutics. Its initial goal is to identify and deploy therapeutic neo-antigens from individual patients’ tumors to develop novel treatments for lung cancer.

TypePublic
HQEmeryville, US
Founded2015
Size (employees)100 (est)-1%
Websitegritstoneoncology.com
Gritstone Oncology was founded in 2015 and is headquartered in Emeryville, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Gritstone Oncology

Andrew Allen

Andrew Allen

Co-Founder, President and Chief Executive Officer
Jayant Aphale

Jayant Aphale

Executive Vice President of Technical Operations
Jean-Marc Bellemin

Jean-Marc Bellemin

Executive Vice President and Chief Financial Officer
Matthew Hawryluk

Matthew Hawryluk

Executive Vice President and Chief Business Officer
Erin E. Jones

Erin E. Jones

Executive Vice President, Global Regulatory Affairs and Quality
Karin Jooss

Karin Jooss

Executive Vice President of Research and Chief Scientific Officer
Show more

Gritstone Oncology Office Locations

Gritstone Oncology has offices in Emeryville, Pleasanton and Cambridge
Emeryville, (HQ)
210 5858 Horton St
Cambridge,
120 40 Erie St
Pleasanton,
4698 Willow Rd
Show all (3)
Report incorrect company information

Gritstone Oncology Financials and Metrics

Gritstone Oncology Revenue

Closing stock price (1-Oct-2018)

13.5
Show all financial metrics
Report incorrect company information

Gritstone Oncology Online and Social Media Presence

Embed Graph
Report incorrect company information

Gritstone Oncology News and Updates

Gritstone Oncology Reports Third Quarter 2018 Financial Results and Recent Business Highlights

Successful Initial Public Offering Raises $95.6 Million in Net Proceeds

Gritstone Oncology expects to begin trading today, prices at $15 per share

Gritstone Oncology Inc. has priced its initial public offering at $15 per share, at the top of a previously-set range, and will offer 6.66 million shares, more than previous plans to offer 6.07 million shares. The cancer-focused biotech company expects to begin trading on Friday on Nasdaq under the…

Gritstone Oncology sets terms for IPO to raise up to $91.1 million

Gritstone Oncology disclosed Monday it has set terms for its initial public offering that is expected to raise up to $91.1 million. The developer of tumor-specific cancer immunotherapies will offer 6.07 million shares in its IPO, which is expected to price between $13 to $15 a share. At $15 a share…
Report incorrect company information

Gritstone Oncology Company Life and Culture

Report incorrect company information

Gritstone Oncology Frequently Asked Questions

  • When was Gritstone Oncology founded?

    Gritstone Oncology was founded in 2015.

  • Who are Gritstone Oncology key executives?

    Gritstone Oncology's key executives are Andrew Allen, Jayant Aphale and Jean-Marc Bellemin.

  • How many employees does Gritstone Oncology have?

    Gritstone Oncology has 100 employees.

  • Who are Gritstone Oncology competitors?

    Competitors of Gritstone Oncology include Virta Health, Novian Health and TopiVert.

  • Where is Gritstone Oncology headquarters?

    Gritstone Oncology headquarters is located at 210 5858 Horton St, Emeryville.

  • Where are Gritstone Oncology offices?

    Gritstone Oncology has offices in Emeryville, Pleasanton and Cambridge.

  • How many offices does Gritstone Oncology have?

    Gritstone Oncology has 3 offices.